AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells
Ontology highlight
ABSTRACT: AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells
PROVIDER: PRJNA799341 | ENA |
REPOSITORIES: ENA
ACCESS DATA